Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Action Potentials | 38 | 2024 | 231 | 10.070 |
Why?
|
| Neurons | 38 | 2024 | 1175 | 7.950 |
Why?
|
| Models, Neurological | 20 | 2024 | 128 | 6.450 |
Why?
|
| Globus Pallidus | 11 | 2024 | 18 | 5.030 |
Why?
|
| Corpus Striatum | 16 | 2024 | 104 | 4.760 |
Why?
|
| Interneurons | 13 | 2020 | 56 | 4.070 |
Why?
|
| Subthalamic Nucleus | 11 | 2023 | 14 | 3.840 |
Why?
|
| Biological Clocks | 8 | 2020 | 53 | 2.740 |
Why?
|
| Nerve Net | 9 | 2021 | 76 | 2.350 |
Why?
|
| Synapses | 8 | 2024 | 180 | 2.160 |
Why?
|
| Electrophysiological Phenomena | 5 | 2021 | 19 | 2.010 |
Why?
|
| Inhibitory Postsynaptic Potentials | 4 | 2024 | 12 | 1.740 |
Why?
|
| Neural Pathways | 8 | 2024 | 124 | 1.690 |
Why?
|
| Neural Inhibition | 8 | 2020 | 48 | 1.670 |
Why?
|
| Animals | 56 | 2024 | 15081 | 1.570 |
Why?
|
| Neostriatum | 6 | 2012 | 26 | 1.540 |
Why?
|
| Membrane Potentials | 9 | 2014 | 223 | 1.440 |
Why?
|
| Excitatory Postsynaptic Potentials | 5 | 2012 | 79 | 1.350 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2016 | 1618 | 1.080 |
Why?
|
| Mice | 17 | 2024 | 5913 | 1.010 |
Why?
|
| Rats | 25 | 2014 | 3483 | 0.950 |
Why?
|
| Patch-Clamp Techniques | 13 | 2019 | 223 | 0.930 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 617 | 0.860 |
Why?
|
| Periodicity | 5 | 2017 | 34 | 0.810 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 4 | 2009 | 8 | 0.750 |
Why?
|
| Acetylcholine | 5 | 2009 | 73 | 0.740 |
Why?
|
| Oscillometry | 2 | 2018 | 7 | 0.720 |
Why?
|
| Synaptic Transmission | 8 | 2012 | 146 | 0.710 |
Why?
|
| Mesencephalon | 4 | 2023 | 41 | 0.670 |
Why?
|
| Computer Simulation | 8 | 2017 | 362 | 0.670 |
Why?
|
| Adaptation, Physiological | 3 | 2009 | 109 | 0.610 |
Why?
|
| Dopamine | 7 | 2011 | 245 | 0.610 |
Why?
|
| Male | 23 | 2024 | 20025 | 0.600 |
Why?
|
| Models, Statistical | 3 | 2014 | 180 | 0.600 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2007 | 79 | 0.600 |
Why?
|
| Calcium | 4 | 2009 | 480 | 0.590 |
Why?
|
| Apamin | 5 | 2009 | 8 | 0.580 |
Why?
|
| Female | 21 | 2024 | 20969 | 0.550 |
Why?
|
| Parvalbumins | 4 | 2023 | 16 | 0.520 |
Why?
|
| Calcium Channels | 5 | 2012 | 76 | 0.500 |
Why?
|
| Cerebral Cortex | 3 | 2016 | 290 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 1609 | 0.490 |
Why?
|
| Afferent Pathways | 1 | 2014 | 37 | 0.490 |
Why?
|
| Biophysical Phenomena | 2 | 2011 | 22 | 0.490 |
Why?
|
| Electrical Synapses | 1 | 2013 | 3 | 0.450 |
Why?
|
| Cell Membrane | 3 | 2010 | 381 | 0.450 |
Why?
|
| Electric Stimulation | 7 | 2024 | 184 | 0.440 |
Why?
|
| Differential Threshold | 2 | 2010 | 5 | 0.440 |
Why?
|
| Tissue Culture Techniques | 3 | 2017 | 32 | 0.440 |
Why?
|
| Locomotion | 1 | 2013 | 97 | 0.420 |
Why?
|
| Nonlinear Dynamics | 2 | 2009 | 33 | 0.410 |
Why?
|
| Animals, Newborn | 6 | 2011 | 343 | 0.410 |
Why?
|
| Synaptic Potentials | 2 | 2023 | 7 | 0.410 |
Why?
|
| Axons | 2 | 2023 | 108 | 0.390 |
Why?
|
| Potassium Channels, Calcium-Activated | 3 | 2005 | 8 | 0.390 |
Why?
|
| Organ Culture Techniques | 4 | 2020 | 103 | 0.370 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2007 | 73 | 0.350 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 61 | 0.350 |
Why?
|
| Cluster Analysis | 1 | 2010 | 195 | 0.350 |
Why?
|
| Dendrites | 2 | 2006 | 55 | 0.350 |
Why?
|
| Ion Channels | 1 | 2009 | 71 | 0.340 |
Why?
|
| Cholinergic Fibers | 2 | 2005 | 10 | 0.320 |
Why?
|
| Basal Ganglia | 2 | 2023 | 17 | 0.320 |
Why?
|
| Algorithms | 5 | 2013 | 465 | 0.320 |
Why?
|
| Linear Models | 3 | 2017 | 275 | 0.310 |
Why?
|
| Calcium Signaling | 2 | 2005 | 101 | 0.300 |
Why?
|
| Calcium Channel Blockers | 5 | 2009 | 56 | 0.300 |
Why?
|
| Time Factors | 6 | 2011 | 1742 | 0.290 |
Why?
|
| Cortical Synchronization | 1 | 2006 | 3 | 0.290 |
Why?
|
| Models, Biological | 2 | 2010 | 677 | 0.280 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2006 | 9 | 0.280 |
Why?
|
| Biophysics | 3 | 2011 | 37 | 0.270 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2009 | 137 | 0.270 |
Why?
|
| Presynaptic Terminals | 1 | 2006 | 53 | 0.270 |
Why?
|
| Potassium Channel Blockers | 4 | 2011 | 33 | 0.260 |
Why?
|
| Acetylcholinesterase | 1 | 2005 | 55 | 0.260 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2023 | 80 | 0.250 |
Why?
|
| Sensory Thresholds | 1 | 2004 | 12 | 0.250 |
Why?
|
| Neurochemistry | 1 | 2004 | 6 | 0.240 |
Why?
|
| Somatosensory Cortex | 1 | 2004 | 24 | 0.240 |
Why?
|
| Neurophysiology | 1 | 2004 | 9 | 0.240 |
Why?
|
| Neuroanatomy | 1 | 2004 | 5 | 0.240 |
Why?
|
| Vibrissae | 1 | 2004 | 33 | 0.240 |
Why?
|
| Tetrodotoxin | 3 | 2009 | 22 | 0.240 |
Why?
|
| Sodium Channel Blockers | 3 | 2009 | 17 | 0.240 |
Why?
|
| Staining and Labeling | 1 | 2004 | 105 | 0.230 |
Why?
|
| Lysine | 1 | 2004 | 113 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 360 | 0.220 |
Why?
|
| Feedback | 3 | 2007 | 53 | 0.210 |
Why?
|
| Ion Channel Gating | 2 | 2010 | 83 | 0.180 |
Why?
|
| Sodium | 2 | 2009 | 103 | 0.170 |
Why?
|
| Tetraethylammonium | 2 | 2011 | 6 | 0.170 |
Why?
|
| Brain | 1 | 2006 | 1346 | 0.160 |
Why?
|
| Corpus Callosum | 1 | 2018 | 12 | 0.160 |
Why?
|
| Sodium Channels | 2 | 2012 | 67 | 0.160 |
Why?
|
| Potassium Channels | 2 | 2012 | 75 | 0.160 |
Why?
|
| Auditory Cortex | 1 | 2018 | 11 | 0.160 |
Why?
|
| Motor Activity | 1 | 2021 | 418 | 0.160 |
Why?
|
| Cells, Cultured | 3 | 2014 | 1518 | 0.150 |
Why?
|
| omega-Conotoxin GVIA | 2 | 2009 | 6 | 0.150 |
Why?
|
| Photic Stimulation | 1 | 2017 | 115 | 0.140 |
Why?
|
| Kinetics | 3 | 2016 | 708 | 0.140 |
Why?
|
| GABA Antagonists | 2 | 2012 | 29 | 0.130 |
Why?
|
| Beta Rhythm | 1 | 2014 | 1 | 0.130 |
Why?
|
| Pyramidal Cells | 2 | 2006 | 63 | 0.130 |
Why?
|
| Electric Impedance | 1 | 2014 | 25 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2014 | 129 | 0.120 |
Why?
|
| Electrophysiology | 2 | 2004 | 136 | 0.120 |
Why?
|
| Fourier Analysis | 1 | 2013 | 43 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 99 | 0.110 |
Why?
|
| Corneal Diseases | 2 | 1986 | 9 | 0.100 |
Why?
|
| Humans | 13 | 2010 | 37093 | 0.100 |
Why?
|
| Elapid Venoms | 1 | 2011 | 16 | 0.100 |
Why?
|
| Organic Chemicals | 1 | 2011 | 35 | 0.100 |
Why?
|
| Stochastic Processes | 1 | 2010 | 10 | 0.090 |
Why?
|
| Receptors, GABA | 1 | 2010 | 25 | 0.090 |
Why?
|
| Receptors, AMPA | 2 | 2010 | 56 | 0.090 |
Why?
|
| Shal Potassium Channels | 1 | 2009 | 1 | 0.090 |
Why?
|
| Fura-2 | 1 | 2009 | 12 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 1 | 2009 | 19 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 108 | 0.080 |
Why?
|
| Poisson Distribution | 1 | 2009 | 38 | 0.080 |
Why?
|
| Potassium | 1 | 2009 | 112 | 0.080 |
Why?
|
| Software | 1 | 2010 | 217 | 0.080 |
Why?
|
| Calcium Channels, N-Type | 1 | 2007 | 6 | 0.080 |
Why?
|
| Ovariectomy | 1 | 1987 | 105 | 0.070 |
Why?
|
| Vitreous Body | 1 | 1986 | 11 | 0.070 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Hyaluronic Acid | 1 | 1986 | 33 | 0.070 |
Why?
|
| RGS Proteins | 1 | 2006 | 6 | 0.070 |
Why?
|
| Laser Therapy | 1 | 1986 | 30 | 0.070 |
Why?
|
| Dendritic Spines | 1 | 2007 | 33 | 0.070 |
Why?
|
| Bone and Bones | 1 | 1987 | 86 | 0.070 |
Why?
|
| Gene Expression | 1 | 2009 | 674 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1987 | 214 | 0.070 |
Why?
|
| Cesium | 1 | 2005 | 7 | 0.060 |
Why?
|
| Barium | 1 | 2005 | 17 | 0.060 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1985 | 2 | 0.060 |
Why?
|
| Parenteral Nutrition | 1 | 1985 | 13 | 0.060 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1985 | 36 | 0.060 |
Why?
|
| Parkinson Disease | 2 | 2006 | 178 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2005 | 103 | 0.060 |
Why?
|
| Thalamus | 1 | 2004 | 30 | 0.060 |
Why?
|
| Rats, Long-Evans | 1 | 2004 | 89 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 38 | 0.060 |
Why?
|
| Biotin | 1 | 2004 | 24 | 0.060 |
Why?
|
| Electrochemistry | 1 | 2004 | 34 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2004 | 35 | 0.060 |
Why?
|
| Electrodes | 1 | 2004 | 45 | 0.060 |
Why?
|
| Neural Conduction | 1 | 2003 | 17 | 0.060 |
Why?
|
| Nifedipine | 1 | 2003 | 10 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2005 | 118 | 0.060 |
Why?
|
| Equipment Design | 1 | 2004 | 124 | 0.060 |
Why?
|
| Energy Intake | 1 | 1985 | 170 | 0.060 |
Why?
|
| Receptors, Dopamine | 1 | 2002 | 25 | 0.050 |
Why?
|
| Receptors, Nicotinic | 1 | 2002 | 106 | 0.050 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2021 | 1 | 0.050 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2021 | 12 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2021 | 314 | 0.040 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 77 | 0.040 |
Why?
|
| Transfection | 1 | 2018 | 523 | 0.040 |
Why?
|
| Allantoin | 1 | 1986 | 1 | 0.040 |
Why?
|
| Caffeine | 1 | 1986 | 28 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 754 | 0.030 |
Why?
|
| Liver | 1 | 1986 | 479 | 0.030 |
Why?
|
| Iontophoresis | 1 | 2010 | 10 | 0.020 |
Why?
|
| Picrotoxin | 1 | 2010 | 14 | 0.020 |
Why?
|
| Isonicotinic Acids | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptors, GABA-B | 1 | 2010 | 11 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2010 | 21 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1970 | 35 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 111 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2010 | 64 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2010 | 87 | 0.020 |
Why?
|
| Sulpiride | 1 | 2007 | 6 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 36 | 0.020 |
Why?
|
| Quinpirole | 1 | 2007 | 16 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2007 | 30 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2007 | 44 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2007 | 141 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 1987 | 64 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 1987 | 31 | 0.020 |
Why?
|
| Minerals | 1 | 1987 | 47 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 1987 | 75 | 0.020 |
Why?
|
| Oxotremorine | 1 | 2006 | 1 | 0.020 |
Why?
|
| Autoreceptors | 1 | 2006 | 2 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2006 | 10 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1986 | 24 | 0.020 |
Why?
|
| Cell Communication | 1 | 2006 | 97 | 0.020 |
Why?
|
| Food, Formulated | 1 | 1985 | 4 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1986 | 210 | 0.020 |
Why?
|
| Nutritional Requirements | 1 | 1985 | 36 | 0.020 |
Why?
|
| Gastric Juice | 1 | 1974 | 1 | 0.010 |
Why?
|
| Pentagastrin | 1 | 1974 | 1 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 435 | 0.010 |
Why?
|
| Ion Transport | 1 | 2003 | 17 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2003 | 20 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 513 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 2002 | 43 | 0.010 |
Why?
|
| Heart Rate | 1 | 1974 | 253 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1015 | 0.010 |
Why?
|
| Addison Disease | 1 | 1972 | 1 | 0.010 |
Why?
|
| Anemia, Pernicious | 1 | 1972 | 1 | 0.010 |
Why?
|
| Vitiligo | 1 | 1972 | 3 | 0.010 |
Why?
|
| Graves Disease | 1 | 1972 | 3 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 1972 | 18 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1985 | 894 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1972 | 36 | 0.010 |
Why?
|
| Infant | 1 | 1985 | 1046 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1972 | 90 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1985 | 1418 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1974 | 646 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 1908 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1986 | 11 | 0.010 |
Why?
|
| Child | 1 | 1985 | 3131 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1986 | 37 | 0.010 |
Why?
|
| Biotransformation | 1 | 1986 | 67 | 0.010 |
Why?
|
| Endothelium | 1 | 1985 | 31 | 0.010 |
Why?
|
| Phosphoric Acids | 1 | 1970 | 1 | 0.010 |
Why?
|
| Pentosephosphates | 1 | 1970 | 4 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1970 | 6 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1970 | 38 | 0.010 |
Why?
|
| Phosphates | 1 | 1970 | 51 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1970 | 40 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1970 | 177 | 0.010 |
Why?
|
| Magnesium | 1 | 1970 | 97 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1970 | 128 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1970 | 196 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1970 | 207 | 0.010 |
Why?
|
| Adult | 3 | 1985 | 11712 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1974 | 22 | 0.000 |
Why?
|
| Gastric Mucosa | 1 | 1974 | 51 | 0.000 |
Why?
|
| Immunoelectrophoresis | 1 | 1972 | 3 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1972 | 57 | 0.000 |
Why?
|
| Antibodies | 1 | 1972 | 141 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1972 | 217 | 0.000 |
Why?
|
| Hypertension | 1 | 1974 | 796 | 0.000 |
Why?
|